Zobrazeno 1 - 5
of 5
pro vyhledávání: '"G A, Ohnmacht"'
Publikováno v:
Cancer research. 61(14)
Methodology for identifying tumor-associated antigens recognized by T cells has been successfully used to clone antigens from melanoma cells. Similar efforts for nonmelanoma tumors have had limited success with few antigens identified. To identify po
Autor:
G A, Ohnmacht, G Q, Phan, S A, Mavroukakis, S M, Steinberg, Y R, Shea, F G, Witebsky, L S, McIntyre, R S, Goodwin, P M, Muehlbauer, K E, Morton, L J, Rogers-Freezer, C A, Seipp, S A, Rosenberg, F M, Marincola
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997). 24(2)
Interleukin-2 (IL-2) has been used to treat patients with metastatic melanoma and renal cell cancer for nearly two decades, and much progress has been made in ameliorating its adverse effects. One bothersome adverse effect, oral pain or oral irritati
Autor:
A I, Riker, U S, Kammula, M C, Panelli, E, Wang, G A, Ohnmacht, S M, Steinberg, S A, Rosenberg, F M, Marincola
Publikováno v:
International journal of cancer. 86(6)
The level of expression of melanoma antigens (MA) may modulate the host immunologic response. Thus, the accurate measurement of MA expression may allow proper patient selection for antigen-specific therapies and yield important information for the ev
Autor:
G A, Ohnmacht, F M, Marincola
Publikováno v:
Journal of cellular physiology. 182(3)
The study of tumor immunology has led to many innovative therapeutic strategies for the treatment of melanoma. The strategies are primarily dependent on melanoma-associated antigen peptide vaccination or T-cell-based therapy. These immunotherapies ar
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 163(12)
The cloning of cancer Ags recognized by T cells has provided potentially new tools to enhance immunity against metastatic cancer. The biological monitoring of effective immunization has, however, remained a dilemma. We describe here a sensitive molec